SCCM Resource Library-Human Neural Stem Cells Improve Functional Outcomes After Cardiac Arrest

Human Neural Stem Cells Improve Functional Outcomes After Cardiac Arrest

Video Transcription

Video Summary

During a presentation, Professor Xiaofen Jia discusses the potential of human neural stem cell therapy in improving functional outcomes after cardiac arrest. The current treatments for brain injury caused by cardiac arrest are not effective. Neural stem cells have shown promise in improving outcomes for stroke, HIE, and TBI. The professor's research focused on the administration of neural stem cells through intranasal and intracerebral routes, with positive results seen in animal models. Additionally, the use of a sugar analog to enhance cell adhesion and interaction with surrounding cells improved the survival rates of transplanted stem cells. This research has implications for the development of stem cell therapies in treating brain injury following cardiac arrest.

Asset Subtitle

Neuroscience, Research, Transplant, 2022

Asset Caption

This session will review the exciting frontier of stem cell therapy for acute neurological injuries, including global anoxic injury, stroke, and spinal cord injury.

Meta Tag

Content Type Presentation

Knowledge Area Neuroscience

Knowledge Area Research

Knowledge Area Transplant

Knowledge Level Advanced

Membership Level Select

Tag Neurology

Tag Outcomes Research

Tag Stem Cells

Year 2022

Keywords

neural stem cell therapy

cardiac arrest

brain injury

animal models

stem cell therapies

	Society of Critical Care Medicine 500 Midway Drive Mount Prospect, IL 60056 USA Phone: +1 847 827-6888 Fax: +1 847 439-7226 Email: support@sccm.org	Contact Us About SCCM Newsroom Advertising & Sponsorship DONATE	MySCCM LearnICU Patients & Families Surviving Sepsis Campaign Critical Care Societies Collaborative	GET OUR NEWSLETTER
© Society of Critical Care Medicine. All rights reserved. \| Privacy Statement \| Terms & Conditions The Society of Critical Care Medicine, SCCM, and Critical Care Congress are registered trademarks of the Society of Critical Care Medicine.